Under the Centre’s new vaccination policy for third phase of inoculation that started from May 1, states and private hospitals have the onus of procuring shots...
Covaxin is among the two vaccines available to Indian citizens to date. Another vaccine is Covishield, manufactured by the Pune-based Serum Institute of India.
Much-awaited phase 3 trial results of Bharat Biotech's Covaxin were announced on Wednesday, which showed an interim efficacy of 81% in preventing the infection after administration...
Prime Minister Narendra Modi on Monday took first shot of Covid-19 vaccine at Delhi's AIIMS hospital and became the first beneficiary in the second phase of...
The much-awaited Covid vaccination drive is set to begin in India on January 16. According to official sources, 3 lakh health workers will be administered the...
Bharat Biotech’s Covaxin, which has been in the eye of the storm following approval by Drugs Controller General of India (DCGI) without completion of Phase 3...
As India awaits the approval of Covid-19 vaccine, Serum Institute of India (SII) has submitted additional data sought by the government boosting hopes that it might...
Britain’s first Covid-19 vaccine rollout hit serious problems as the medicines regulator on Wednesday issued a warning for those with a serious allergy to vaccines, medicines...
Haryana health minister Anil Vj has tested positive for the coronavirus, two weeks after receiving the trial dosage of coronavirus vaccine Covaxin.
The PM will later visit Bharat Biotech in Hyderabad and Serum Institute of India in Pune to review their Covid-19 vaccine development and manufacturing process.